Discover how Somru BioScience delivers high-quality, automation-driven bioanalytical services for drug discovery, biosimilar development, cell and gene therapy, vaccine research, and immunogenicity assessment. Download our white paper to explore innovative solutions that enhance your R&D pipeline.
In today’s fast-paced pharmaceutical landscape, the journey from concept to clinic demands not only scientific excellence but also speed, flexibility, and compliance. That’s where Contract Research Organizations (CROs) like Somru BioScience step in – offering a unique combination of innovation, automation, and regulatory expertise to accelerate biopharma development.
Empowering Discovery from the Start
Somru BioScience’s services start right at the heart of discovery. Through Amplatto™ Drug Discovery, the company supports early-stage in vivo studies, ensuring compliance with Canadian and international animal welfare regulations. Their state-of-the-art facilities and ethical research practices help guide early target validation through to candidate selection.
Biosimilar Development Made Simple
With biosimilars rising as a cost-effective alternative to biologics, Somru’s advanced biosimilar development platform equips companies with a validated suite of reagents, assays, and scientific solutions to maximize their pipeline potential.
Next-Gen Support for Cell and Gene Therapy
Somru’s bioanalytical capabilities go deep. Their scientists specialize in customized molecular, immunoassay, and cell-based assays to evaluate the biodistribution, safety, efficacy, and immunogenicity of cutting-edge cell and gene therapies. With regulatory alignment in mind, they help innovators move forward with confidence.
A Smarter Approach to Vaccine Development
In the age of precision immunology, Somru has pioneered immunological fingerprinting technology—enabling vaccine developers to distinguish lead candidates via cytokine profiling. This includes both Th1 (e.g., IL-2, IFN-γ) and Th2 (e.g., IL-4, IL-10) responses, streamlining vaccine candidate evaluation in vitro or in vivo.
Tackling Immunogenicity from the Start
Understanding and mitigating immunogenicity risk is critical to biologics development. Somru’s proprietary tools help sponsors anticipate and address these risks early, ultimately enhancing the value of their R&D investment.
Where Science Meets Automation
Somru isn’t just about expertise—they’re about execution. Their GxP-compliant services are driven by automation platforms (e.g., Hamilton, Opentrons, Tecan), combining quality and speed for large molecule bioanalytical services. With integrated tools like Aegyris™, Watson LIMS, and automated readers, Somru is streamlining workflows like never before.
Ready to Accelerate Your Pipeline?
Whether you’re developing biosimilars, vaccines, or gene therapies, Somru BioScience is ready to partner with you. Consult with one of their scientists today and experience the synergy of science, strategy, and speed.
📧 service@somrubioscience.com
📍 19 Innovation Way, Charlottetown, PE, Canada
🌐 www.somru.ca/cro
